GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vimian Group VIMIAN.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

42.10

+0.24%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€425.0m

FY2018FY2025

Net income

€31.3m

FY2018FY2025

Free cash flow

€90.6m

FY2018FY2025

Shareholders' equity

€698.9m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue€425.0m€374.8m€331.7m€281.3m€173.3m€137.8m€24.5m€8.1m
Gross profit€292.8m€258.3m€229.4m€194.0m€122.8m€95.5m€15.4m€4.6m
Research and development——€5.7m€8.4m€2.4m———
Operating income€73.6m€49.2m€41.3m€39.4m€21.6m€74.8m€1.3m−€1.1m
Net income€31.3m€18.5m€9.8m−€7.2m€6.6m€52.8m−€1.2m−€790,000
Diluted earnings per share0.060.040.02-0.020.020.14-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets€1.11bn€1.11bn€973.7m€923.6m€640.7m€456.3m€99.1m€33.2m
Cash and short-term investments€55.0m€64.8m€37.5m€42.2m€55.1m€29.7m€12.0m€1.5m
Total liabilities€401.0m€403.3m€447.0m€442.1m€282.1m€182.0m€47.1m€13.6m
Debt€238.7m€233.6m€313.8m€221.0m€180.4m€85.9m€15.5m€6.7m
Shareholders' equity€698.9m€699.9m€526.4m€481.8m€357.4m€224.0m€40.9m€19.2m
Shares outstanding528m525m457m441m389m377m529m529m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations€105.7m€58.1m−€28.6m€25.3m€16.0m€4.8m€1.5m−€2.0m
Capital spending−€15.1m−€14.2m−€14.9m−€10.3m−€11.5m−€5.6m−€1.1m−€279,000
Free cash flow€90.6m€43.9m−€43.5m€15.0m€4.5m−€793,000€467,000−€2.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€120.0m€116.0m€109.0m€104.3m€104.3m€107.5m€104.9m€87.6m
Gross profit€23.1m€81.1m€73.7m€72.3m€72.1m€74.8m€69.7m€61.2m
Operating income€23.1m€21.1m€26.0m€17.5m€14.5m€15.6m€12.5m€10.1m
Net income€8.3m€9.8m€12.2m€6.5m€8.3m€4.3m€12.2m−€2.1m
Diluted earnings per share0.020.020.020.010.020.010.02-0.00
Cash from operations€4.0m€22.0m€56.0m€10.0m€22.0m€17.0m€17.0m€16.0m
Capital spending−€3.0m−€3.0m−€5.0m−€1.0m−€3.0m−€1.0m−€1.0m−€2.0m
Free cash flow€1.0m€19.0m€51.0m€9.0m€19.0m€16.0m€16.0m€14.0m
Total assets€1.19bn€1.16bn€1.11bn€1.12bn€1.14bn€1.10bn€1.10bn€1.06bn
Cash and short-term investments€51.7m€50.6m€55.0m€51.3m€67.5m€60.1m€60.1m€39.2m
Debt€266.9m€241.4m€233.5m€5.0m€282.2m€211.6m€220.6m€243.4m
Shareholders' equity€737.0m€722.5m€698.9m€686.1m€682.9m€689.8m€689.8m€667.5m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin68.9%68.9%69.2%69.0%70.9%69.3%
Operating margin15.7%13.1%13.1%4.3%11.2%42.2%
Net margin7.4%4.9%3.0%-2.6%3.8%38.3%
Return on equity4.5%2.6%1.9%-1.5%1.8%23.6%
Return on assets2.8%1.7%1.0%-0.8%1.0%11.6%
Free cash flow yield0.6%0.3%-0.1%0.2%0.2%0.1%
Revenue growth13.4%13.0%17.9%62.3%25.8%461.5%
Earnings growth69.2%88.0%-236.7%-209.3%-87.5%-4402.7%
Current ratio1.95x2.03x2.12x1.24x1.81x1.22x
Debt to equity0.33x0.32x0.58x0.44x0.48x0.37x
Equity ratio63.0%63.1%54.1%52.2%55.8%49.1%
Interest coverage3.17x1.93x2.25x1.08x2.90x8.10x
R&D as a share of sales——1.7%3.0%1.4%—
Buybacks as a share of market value-0.6%-14.8%-3.7%-13.2%-3.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.7%25.3%—
Operating income23.2%-0.3%—
Net income—-9.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin68.9%69.0%69.2%—
Operating margin15.3%14.4%17.4%—
Net margin6.2%3.7%6.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings46.9103.4126.0-152.7429.6
Price to sales3.55.13.73.916.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.